Author(s):
Garud Harshada Sudam, Bramhane Omkar Bapurao, Prafulla Raosaheb Avhad
Email(s):
garudharshada2003@gmail.com
DOI:
10.52711/2231-5713.2026.00026 
Address:
Garud Harshada Sudam, Bramhane Omkar Bapurao, Prafulla Raosaheb Avhad
Shantiniketan College of Pharmacy, A/P Dhotre (B. K), Tal. Parner, Ahmednagar, Maharastra – 414304.
*Corresponding Author
Published In:
Volume - 16,
Issue - 2,
Year - 2026
ABSTRACT:
Recent years have seen scientific and technological advancements in the investigation and development of novel drug delivery systems by addressing physiological problems such short stomach residency periods and irregular gastric emptying timings. Some of the techniques being used to increase the stomach residency times include polymeric bioadhesive systems, floating drug delivery systems, swelling and expanding systems, changed-shape systems, high-density systems, and other delayed gastric emptying devices. The most recent developments in FDDS technology, including commercially available goods and patented delivery methods, are discussed in this study along with their advantages and potential applications in oral controlled drug administration in the future. The stomach's ability to absorb medications may be enhanced by prolonged GRT. Some of the techniques currently employed to extend the GRT include modified-shape systems, high-density systems, polymeric bioadhesive systems, swelling and expanding systems, floating drug delivery systems (FDDS), and various delayed gastric emptying devices. In vivo absorption qualities are improved by drugs manufactured in these systems that have a limited absorption window. Furthermore, local medication delivery to the stomach and proximal small intestine would be facilitated by gastroretention. As a result, gastroretention might help expand access to new products, which would improve treatment effectiveness and offer patients major benefits. Examining the most recent studies and technical developments in the development of gastroretentive dosage forms is the goal of this presentation.
Cite this article:
Garud Harshada Sudam, Bramhane Omkar Bapurao, Prafulla Raosaheb Avhad. Floating Drug Delivery: A Novel Approach. Asian Journal of Pharmacy and Technology. 2026; 16(2):182-6. doi: 10.52711/2231-5713.2026.00026
Cite(Electronic):
Garud Harshada Sudam, Bramhane Omkar Bapurao, Prafulla Raosaheb Avhad. Floating Drug Delivery: A Novel Approach. Asian Journal of Pharmacy and Technology. 2026; 16(2):182-6. doi: 10.52711/2231-5713.2026.00026 Available on: https://ajptonline.com/AbstractView.aspx?PID=2026-16-2-11
REFERENCES:
1. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021 Sep 29; 26(19): 5905.
2. Hoffman A, Stepensky D, Lavy E, Eyal S, Klausner E, Friedman M. Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. International journal of pharmaceutics. 2004 Jun 11; 277(1-2): 141-53.
3. Homayun B, Lin X, Choi HJ. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics. 2019 Mar 19; 11(3): 129.
4. Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P, Bannerjee SK. Drug delivery systems: An updated review. International journal of pharmaceutical investigation. 2012 Jan; 2(1): 2.
5. Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery systems. Expert opinion on drug delivery. 2006 Mar 1; 3(2): 217-33.
6. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. Journal of Controlled release. 2000 Feb 3; 63(3): 235-59.
7. Staples M, Daniel K, Cima MJ, Langer R. Application of micro-and nano-electromechanical devices to drug delivery. Pharmaceutical research. 2006 May; 23(5): 847-63.
8. Benet LZ, Kroetz D, Sheiner L, Hardman J, Limbird L. Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination. Goodman and Gilman’s the pharmacological basis of therapeutics. 1996; 3: e27.
9. Muller PY, Milton MN. The determination and interpretation of the therapeutic index in drug development. Nature reviews Drug discovery. 2012 Oct; 11(10): 751-61.
10. Shah SH, Patel JK, Patel NV. Stomach specific floating drug delivery system: A review. Int J Pharm Tech Res. 2009 Jul 1; 1(3): 623-33.
11. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. Journal of Controlled release. 2000 Feb 3; 63(3): 235-59.
12. Kumar R, Philip A. Gastroretentive dosage forms for prolonging gastric residence time. International Journal of Pharmaceutical Medicine. 2007 Apr; 21(2): 157-71.
13. Abu-Hijleh MF, Habbal OA, Moqattash ST. The role of the diaphragm in lymphatic absorption from the peritoneal cavity. Journal of anatomy. 1995 Jun; 186(Pt 3): 453.
14. Soybel DI. Anatomy and physiology of the stomach. Surgical Clinics. 2005 Oct 1; 85(5): 875-94.
15. Schulze K. Imaging and modelling of digestion in the stomach and the duodenum. Neurogastroenterology & Motility. 2006 Mar; 18(3): 172-83.
16. Iglesias N, Galbis E, Romero-Azogil L, Benito E, Lucas R, García-Martín MG, de-Paz MV. In-depth study into polymeric materials in low-density gastroretentive formulations. Pharmaceutics. 2020 Jul 7; 12(7): 636.
17. Felton LA. Aqueous polymeric coatings for pharmaceutical dosage forms. CRC Press; 2016 Sep 19.
18. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan—a review. Journal of controlled release. 2006 Aug 10;114(1):1-4.
19. Iglesias N, Galbis E, Romero-Azogil L, Benito E, Lucas R, García-Martín MG, de-Paz MV. In-depth study into polymeric materials in low-density gastroretentive formulations. Pharmaceutics. 2020 Jul 7; 12(7): 636.
20. Hausmann R, Panizza U, Stein E. Why do countries float the way they float? Journal of development economics. 2001 Dec 1; 66(2): 387-414.
21. Jadhav S, Gangurde A. A bird eye view on effervescent drug delivery system. Int J Drug Deliv Technol. 2023; 13(3): 1046-58.
22. Sayyad ST, Anwar MK, Pathan MG, Bilal AI, Shaikh RS, Kute MV. A Review on Formulation of Conventional Drug Delivery System and Novel Drug Delivery System.
23. Zhou Y, Zhang ML, Yuan BJ, Yuan JQ, Zhao XF, Zhao L, Ren HQ. Herbal carrier-based floating microparticles of diltiazem hydrochloride for improved cardiac activity. Tropical Journal of Pharmaceutical Research. 2017 Jul 3; 16(6): 1239-44.
24. LeWitt PA. Levodopa therapy for Parkinson's disease: pharmacokinetics and pharmacodynamics. Movement Disorders. 2015 Jan; 30(1): 64-72.
25. Graham D, Agrawal N, Roth S. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. The Lancet. 1988 Dec 3; 332(8623): 1277-80.
26. Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer—a plan to move forward. Clinical Cancer Research. 2006 Jun 15; 12(12): 3661-97.
27. Bharate SS, Vishwakarma RA. Impact of preformulation on drug development. Expert opinion on drug delivery. 2013 Sep 1; 10(9): 1239-57.
28. Patil JM, Hirlekar RS, Gide PS, Kadam VJ. Trends in floating drug delivery systems. Journal of scientific and industrial research. 2006 Jan 1; 65(1): 11.
29. Iglesias N, Galbis E, Romero-Azogil L, Benito E, Lucas R, García-Martín MG, de-Paz MV. In-depth study into polymeric materials in low-density gastroretentive formulations. Pharmaceutics. 2020 Jul 7; 12(7): 636.
30. Ali MN, Malek A, Akter P, Al Juhan A, Safrin F, Akter F. A Comprehensive Review on Floating Drug Delivery System. Saudi J Med Pharm Sci. 2025; 11(5): 383-93.
31. Tinto WF, Elufioye TO, Roach J. Waxes. In Pharmacognosy 2017 Jan 1 (pp. 443-455). Academic Press.
32. Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. International Journal of Pharmaceutics. 2010 Jun 15;392(1-2):1-9.
33. Li J, Wu Y. Lubricants in pharmaceutical solid dosage forms. Lubricants. 2014 Feb 25; 2(1): 21-43.
34. Jin H, Zhou W, Cao J, Stoyanov SD, Blijdenstein TB, De Groot PW, Arnaudov LN, Pelan EG. Super stable foams stabilized by colloidal ethyl cellulose particles. Soft Matter. 2012; 8(7): 2194-205.
35. Pawar VK, Kansal S, Garg G, Awasthi R, Singodia D, Kulkarni GT. Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems. Drug Delivery. 2011 Feb 1; 18(2): 97-110.
36. Benet LZ, Kroetz D, Sheiner L, Hardman J, Limbird L. Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 1996; 3: e27.
37. Timmermans J, Moës AJ. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. Journal of Pharmaceutical Sciences. 1994 Jan; 83(1): 18-24.
38. Hogben CA, Tocco DJ, Brodie BB, Schanker LS. On the mechanism of intestinal absorption of drugs. The Journal of Pharmacology and Experimental Therapeutics. 1959 Apr 1; 125(4): 275-82.
39. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiological Reviews. 2008 Oct; 88(4): 1547-65.
40. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Development and Industrial Pharmacy. 1996 Jan 1; 22(6): 531-9.
41. Reddy LH, Murthy RS. Floating dosage systems in drug delivery. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2002; 19(6).
42. Eberle VA. Floating gastroretentive drug delivery systems based on functionalized calcium carbonate (Doctoral dissertation, Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel).